Skip to content
Recall Observatory FDA recall evidence

Drug product

Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-047-24.

D-1035-2018

August 01, 2018

Class III

Product summary

Firm
Baxter Healthcare Corporation
Event
Event 80653
Status
Terminated
Classification
Class III
Quantity
106,320 bags
Official record key
drug-enforcement:D-1035-2018

Official wording

Reason: Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Code information: Lot#: A0A0954, A0A0958, A0A0970, Exp 09/19

Distribution pattern: Nationwide USA and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent